Scientists at the Salk Institute have discovered an on-and-off “switch” in cells that may hold the key to healthy aging. The switch controls the growth of telomeres, the timekeepers of cells
This switch points to a way to encourage healthy cells to keep dividing and generating, for example, new lung or liver tissue, even in old age.
In our bodies, newly divided cells constantly replenish lungs, skin, liver and other organs. However, most human cells cannot divide indefinitely–with each division, a cellular timekeeper at the ends of chromosomes shortens. When this timekeeper, called a telomere, becomes too short, cells can no longer divide, causing organs and tissues to degenerate, as often happens in old age. But there is a way around this countdown: some cells produce an enzyme called telomerase, which rebuilds telomeres and allows cells to divide indefinitely.
In a new study published September 19th in the journal Genes and Development, scientists at the Salk Institute have discovered that telomerase, even when present, can be turned off.
“Previous studies had suggested that once assembled, telomerase is available whenever it is needed,” says senior author Vicki Lundblad, professor and holder of Salk’s Ralph S. and Becky O’Connor Chair. “We were surprised to discover instead that telomerase has what is in essence an ‘off’ switch, whereby it disassembles.”
Understanding how this “off” switch can be manipulated–thereby slowing down the telomere shortening process–could lead to treatments for diseases of aging (for example, regenerating vital organs later in life).
The Latest on: Telomerase
[google_news title=”” keyword=”Telomerase” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Telomerase
- Geron to Announce First Quarter 2024 Financial Results on May 2, 2024on April 25, 2024 at 1:30 pm
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that it will release its first quarter 2024 financi ...
- Amicus Therapeutics gets grant for treatment of fabry disease with migalastat for specific mutationson April 24, 2024 at 6:10 am
Discover Amicus Therapeutics' groundbreaking patent for treating Fabry disease with migalastat, targeting specific mutations in a-galactosidase A. Learn about the innovative method and potential ...
- 3 Red-Hot Biotech Rockets Blasting Off in 2024on April 24, 2024 at 5:00 am
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The economy is currently on a stable trajectory and is poised for sustained ...
- Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meetingon April 24, 2024 at 12:14 am
Presentation Details: Abstract Number: LBA9519 Abstract Title: Ipilimumab and nivolumab plus UV1, an anticancer vaccination against telomerase, in advanced melanoma. Session Title: Poster Session – ...
- MAIA Biotechnology Announces $1.00 Million Private Placementon April 23, 2024 at 5:51 am
The gross proceeds from the offering are expected to be approximately $1.00 million, prior to offering expenses payable by the Company. The Company intends to use the net proceeds from the offering ...
- Can Vitamin D supplements keep you young? New research reveals how you can slow down ageingon April 22, 2024 at 11:33 pm
Vitamin D is found in certain foods, it can be difficult to get enough from your diet alone or if you don't get enough sun exposure.
- GSK gets grant for treatment of lung cancer with TIM-3 binding agentson April 22, 2024 at 5:18 am
Discover a groundbreaking patent for treating lung cancer with specific TIM-3 binding agents and anti-PD-1 antibodies. Learn about the dosage regimen and administration process for effective treatment ...
- Could Vitamin D Be The Secret to Slowing Human Aging?on April 21, 2024 at 6:53 pm
It's the holy grail for some people: how to possibly slow aging or wind back our body's biological clock despite the years ticking by.
- Ultimovacs downsizes to funnel funds to cancer vaccine programmeon April 17, 2024 at 7:09 am
Ultimovacs has implemented cash-saving strategies, including a 40% workforce reduction, to extend its reserves into Q4 2025. The operational adjustments are expected to provide a cash runway beyond ...
- Mouse study finds small extracellular vesicles from young blood extend lifespan and restore physiological functionson April 16, 2024 at 9:05 am
New research presents a significant discovery: small extracellular vesicles (sEVs) from the blood of young mice possess the capacity to dramatically extend lifespan, rejuvenate whole-body physiology ...
via Bing News